Henry A. Fernandez - Jan 27, 2025 Form 4 Insider Report for MSCI Inc. (MSCI)

Role: Chairman and CEO, Director
Signature: /s/ Cecilia Aza, attorney-in-fact
Stock symbol: MSCI
Transactions as of: Jan 27, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/29/2025, 04:07 PM
Previous filing: Jan 2, 2025
Next filing: Feb 4, 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MSCI	Option to purchase common stock	Award	$0	+29.6K		$0.00	29.6K	Jan 27, 2025	Common Stock	29.6K	$549.83	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 27, 2025 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 3, 2022 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2022 and ending on December 31, 2024. The performance condition for the PSOs was met with respect to 29,564 shares of common stock, and the PSOs are scheduled to vest on February 3, 2025.

Content

Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 27, 2025 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 3, 2022 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2022 and ending on December 31, 2024. The performance condition for the PSOs was met with respect to 29,564 shares of common stock, and the PSOs are scheduled to vest on February 3, 2025.